These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 15586745)

  • 1. Seventy-four defibrillations for sotalol-induced torsades de pointes.
    Sürücü H; Tatli E; Değirmenci A; Gökmen G
    Indian Heart J; 2004; 56(4):340-2. PubMed ID: 15586745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sotalol-induced torsades de pointes in patients with renal failure.
    Dancey D; Wulffhart Z; McEwan P
    Can J Cardiol; 1997 Jan; 13(1):55-8. PubMed ID: 9039065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Torsades de pointes during low-dosage sotalol therapy in haemodialysis patients.
    Huynh-Do U; Wahl C; Sulzer M; Bühler H; Keusch G
    Nephrol Dial Transplant; 1996 Jun; 11(6):1153-4. PubMed ID: 8671988
    [No Abstract]   [Full Text] [Related]  

  • 4. Torsade de pointes with amiodarone in a patient with previous torsade during beta-receptor blockade.
    Skanes AC; Morton BC; Green MS; Tang AS
    Can J Cardiol; 1997 Apr; 13(4):383-6. PubMed ID: 9141970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline values and sotalol-induced changes of ventricular repolarization duration, heterogeneity, and instability in patients with a history of drug-induced torsades de pointes.
    Couderc JP; Kaab S; Hinterseer M; McNitt S; Xia X; Fossa A; Beckmann BM; Polonsky S; Zareba W
    J Clin Pharmacol; 2009 Jan; 49(1):6-16. PubMed ID: 18957528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sotalol--atrial fibrillation, reduced renal function and sudden death].
    Bathen J; Madsen S
    Tidsskr Nor Laegeforen; 1998 Oct; 118(26):4086-7. PubMed ID: 9844513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sotalol and torsades de pointes ventricular tachycardia].
    Petersen HH; Sandøe E
    Ugeskr Laeger; 1996 May; 158(19):2711-6. PubMed ID: 8744073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Torsades de pointes with a severely prolonged QT interval induced by an initial low dose sotalol intake.
    Yalta K; Turgut O; Yilmaz A; Yilmaz MB; Kendirlioglu O; Karadas F
    Int J Cardiol; 2007 Apr; 116(3):e95-7. PubMed ID: 17126428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ciprofloxacin induced acquired long QT syndrome in a patient under class III antiarrhythmic therapy.
    Keivanidou A; Arnaoutoglou C; Krommydas A; Papanikolaou G; Tsiptses K; Chrisopoulos C; Kirpizidis C
    Cardiol J; 2009; 16(2):172-4. PubMed ID: 19387967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemiparesis and torsade de pointes under low-dose sotalol therapy].
    Sieber C; Weiss P; Follath F
    Schweiz Med Wochenschr; 1990 Sep; 120(38):1397-9. PubMed ID: 1699270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monotherapy versus combination therapy with class III antiarrhythmic agents to attenuate transmural dispersion of repolarization: a potential risk factor for torsade de pointes.
    Shah SA; Kluger J; White CM
    Pharmacotherapy; 2007 Sep; 27(9):1297-305. PubMed ID: 17723083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Torsades de pointes with administration of high-dose intravenous d-sotalol to a patient with congestive heart failure.
    Gottlieb SS; Cines M; Marshall J
    Pharmacotherapy; 1997; 17(4):830-1. PubMed ID: 9250567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful haemodialysis in sotalol-induced torsade de pointes in a patient with progressive renal failure.
    van Uum SH; van den Merkhof LF; Lucassen AM; Wuis EW; Diemont W
    Nephrol Dial Transplant; 1997 Feb; 12(2):331-3. PubMed ID: 9132656
    [No Abstract]   [Full Text] [Related]  

  • 14. Gastroenteritis with severe consequences: a case of sotalol-induced torsades de pointes.
    Michiels V; Miljoen H; Vrints C
    Acta Cardiol; 2009 Dec; 64(6):839-42. PubMed ID: 20128168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sotalol-induced torsade de pointes tachycardia in a 15-month-old infant].
    Sasse M; Paul T; Bergmann P; Kallfelz HC
    Z Kardiol; 1995 Oct; 84(10):863-6. PubMed ID: 7502575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained torsade de pointes occurring early during oral sotalol therapy for atrial fibrillation recurrence prophylaxis in a patient without heart disease.
    D'Aloia A; Faggiano P; Brentana L; Boldini A; Pedrinazzi C; Procopio R; Dei Cas L
    Int J Cardiol; 2005 Dec; 105(3):337-9. PubMed ID: 15985302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Conversion to sinus rhythm].
    Brunckhorst CB
    Praxis (Bern 1994); 2006 Feb; 95(7):247-8. PubMed ID: 16524116
    [No Abstract]   [Full Text] [Related]  

  • 18. Sotalol-induced torsades de pointes successfully treated with hemodialysis after failure of conventional therapy.
    Singh SN; Lazin A; Cohen A; Johnson M; Fletcher RD
    Am Heart J; 1991 Feb; 121(2 Pt 1):601-2. PubMed ID: 1990770
    [No Abstract]   [Full Text] [Related]  

  • 19. Torsades de pointes from terfenadine and sotalol given in combination.
    Feroze H; Suri R; Silverman DI
    Pacing Clin Electrophysiol; 1996 Oct; 19(10):1519-21. PubMed ID: 8904547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Torsades de Pointes: a rare complication of an extra-adrenal pheochromocytoma.
    Methe H; Hinterseer M; Wilbert-Lampen U; Beckmann BM; Steinbeck G; Kääb S
    Hypertens Res; 2007 Dec; 30(12):1263-6. PubMed ID: 18344633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.